| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/20/2008 | US20080069893 Compositions for repair of defects in osseous tissues, and methods of making the same |
| 03/20/2008 | US20080069889 Mixture of polysaccharide and binder; reverse agglomeration |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069863 Device for treatment of disorders in the oral cavity with nitric oxide, and manufacturing process for the same |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069858 Insertable medical equipment; for vascular system |
| 03/20/2008 | US20080069857 Aqueous solution containing polysaccharides; insertion into body cavity; crosslinking |
| 03/20/2008 | US20080069855 Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
| 03/20/2008 | US20080069853 Sustained release of antibodies in milk; insertion of antigen releasing device in mammary glands lymph nodes |
| 03/20/2008 | US20080069837 Composition and method for treating cancer using herpes virus |
| 03/20/2008 | US20080069835 Diphtheria, tetanus, diphtheria, deactivated polio virus, hepatitis B surface antigen in container with protein carrier |
| 03/20/2008 | US20080069833 Anticancer agents; mixture of fusion protein and yeast vehicle |
| 03/20/2008 | US20080069831 Vaccines; fusion protein; induce immunology response |
| 03/20/2008 | US20080069830 Isolation Dna; nucleotide sequences; genetic engineering |
| 03/20/2008 | US20080069828 Detection of glandular disorders; bone disease ; calibrate different peptide fragments from whole parathyroid hormone; binding to antibody |
| 03/20/2008 | US20080069827 miRNA of HSV-LAT and uses thereof |
| 03/20/2008 | US20080069826 Novel Genes Associated with the Maintenance of Differentiation of Smooth Muscle Cells |
| 03/20/2008 | US20080069824 Size-variable strain-specific protective antigen for Potomac horse fever |
| 03/20/2008 | US20080069823 Attenuation of Reperfusion Injury |
| 03/20/2008 | US20080069822 Immunoglobulins; cell line; screening; side effect reduction |
| 03/20/2008 | US20080069820 Mutations within light chain variable domain; antitumor agents |
| 03/20/2008 | US20080069818 Method of Increasing Efficacy of Tumor Cell Killing Using Combinations of Anti-Neoplastic Agents |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069802 Glycosylated adenovirus particles; capsids; tumor suppressors; gene therapy |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | DE202007017725U1 Medizinisches Blütengetränk aus der Gemüse- und/oder Obstblüte Medical flowers drink from the vegetable and / or fruit blossom |
| 03/20/2008 | CA2663293A1 Compositions and methods for treatment of chronic fatigue syndrome and neurodegenerative diseases |
| 03/20/2008 | CA2663234A1 Novel phenylacetic acid derivative |
| 03/19/2008 | EP1900811A1 Enriched central nervous system cell populations |
| 03/19/2008 | EP1900374A1 Angiogenetic agent containing adrenomedulin as the active ingredient |
| 03/19/2008 | EP1900364A2 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 03/19/2008 | EP1898921A1 Compositions and methods for treating sleep disorders |
| 03/19/2008 | EP1682122B1 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1532130A4 Process for the production of an immunosuppressant |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1458380B1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
| 03/19/2008 | EP1442024B1 AMINOBENZAMIDE DERIVATIVES AS GLYCOGEN SYNTHASE KINASE 3$g(b) INHIBITORS |
| 03/19/2008 | EP1438964B1 Process for producing collagen production enhancers and use thereof |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | EP1423103A4 Compositions and methods for modulation of darpp-32 phosphorylation |
| 03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
| 03/19/2008 | EP1362031B1 Pharmaceutically active piperidine derivatives |
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1303496B9 Pyrimidine derivatives |
| 03/19/2008 | EP1300141B1 Medical composition kit for treating lesioned abnormal tissue |
| 03/19/2008 | EP1149091B1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/19/2008 | EP1042293B1 Substituted pyridine and pyridazine compounds and their pharmaceutical use |
| 03/19/2008 | CN101143221A Central airway administration for systemic delivery of therapeutics |
| 03/19/2008 | CN101143217A Treatment of neurological and neuropsychological disorders |
| 03/19/2008 | CN101143214A Important regulating gene RPS6KA2 for IL-2RG signal pathway |
| 03/19/2008 | CN101143197A Bone infarction granule |
| 03/19/2008 | CN101143192A Therapeutic gastrodia extracts |
| 03/19/2008 | CN101143118A Chest and abdomen covering type umbilical hernia belt for infantile and its manufacturing method |
| 03/19/2008 | CN100375631C Chinese traditional medicine composition for relieving side effects of hormones |
| 03/19/2008 | CN100375623C Compound medicine for treating meat chicken ascites |
| 03/19/2008 | CN100375619C Medicinal compositions improving brain function and method for improving brain function |
| 03/19/2008 | CN100375610C Dripping pills of honey suckle and its preparation method |
| 03/18/2008 | US7345180 Compound inhibiting dipeptidyl peptidase IV |
| 03/18/2008 | US7345174 Selectively inducing terminal differentiation of neoplastic cells; antiproliferative agents; antineoplastic agents; antitumor agents; melanomes; acute leukemia, multiple myeloma; carcinomas; neuroblastoma; N-t-butoxycarbonyl- omega -methyl - alpha -aminosuberateanilide |
| 03/18/2008 | US7345172 Intercalation compound for use in the diagnosis and detection of genetic disorders; sterically demanding nucleotide intercalating compounds and methods for detecting base pair mismatches in nucleic acid sequences |
| 03/18/2008 | US7345151 Antagonists specific for denatured collagen and methods of using same |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | US7345088 Synergistic mixtures |
| 03/18/2008 | US7345079 Treatment of disorder related to low cyclic GMP levels |
| 03/18/2008 | US7345070 Side effects reduction; Diabetes mellitus, Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; 3-{4-[2-(2-phenyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid |
| 03/18/2008 | US7345068 Aromatic amino acid derivatives and medicinal compositions |
| 03/18/2008 | US7345066 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345063 Amides, preparation and therapeutic use as modulators of CCR-receptor activity |
| 03/18/2008 | US7345062 Substituted acylhydroxamic acids and method of reducing TNFαlevels |
| 03/18/2008 | US7345050 Imidazo(1,2a)pyridine or pyrazolo(2,3a)pyridine derivatives; Alzheimer's and Parkinson's Disease; nervous system, brain, and psychological disorders |
| 03/18/2008 | US7345045 Pyrido-pyrimidine compounds as medicaments |
| 03/18/2008 | US7345036 (Pyrido/thieno)—[f]—oxazepine-5-one derivatives |
| 03/18/2008 | US7345024 Pharmaceutical preparation, method for its production as well as its use |
| 03/18/2008 | US7345023 Treatment of hyperproliferative conditions of body surfaces |
| 03/18/2008 | CA2448908C Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 03/18/2008 | CA2345248C Use of prostanoid antagonists for the treatment of primary headache disorders |
| 03/18/2008 | CA2323839C Treatment of neuropathy |
| 03/18/2008 | CA2293705C Process for obtaining quinapryl hydrochloride and solvates useful for isolating and purifying quinapryl hydrochloride |
| 03/18/2008 | CA2288705C Use of quinazoline compounds for the treatment of polycystic kidney disease |
| 03/18/2008 | CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 03/18/2008 | CA2219659C Rapamycin derivatives |
| 03/18/2008 | CA2185043C Monoclonal antibodies recognizing tie-receptor and their use |
| 03/18/2008 | CA2167980C Cgrp antagonist used in a cosmetic composition; pharmaceutical or dermatologic composition produced |
| 03/18/2008 | CA2166102C Redirection of cellular immunity by receptor chimeras |
| 03/13/2008 | WO2008030892A2 Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
| 03/13/2008 | WO2008029912A1 Compound having benzamide skeleton and cyclooxygenase (cox-1)-selective inhibitory activity |
| 03/13/2008 | WO2008029882A1 2-alkyl-6-(pyrazolopyridin-4-yl)pyridazinone derivative, addition salt thereof, and pde inhibitor comprising the derivative or the salt as active ingredient |
| 03/13/2008 | WO2008029879A1 Moisturizing agent, cell-activating agent and antioxidant |
| 03/13/2008 | WO2008029876A1 Salt of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and crystal thereof |
| 03/13/2008 | WO2008029871A1 Nerve fiber degeneration inhibitor |
| 03/13/2008 | WO2008029846A1 Lipase inhibitor |
| 03/13/2008 | WO2008029829A1 Pyrazolopyridine derivative and phosphodiesterase (pde) inhibitor containing the same as active ingredient |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008029790A1 Novel nucleic acid |
| 03/13/2008 | WO2008029565A1 Compound having inhibitory activity on histone deacetylase, and pharmaceutical comprising the compound as active ingredient |
| 03/13/2008 | WO2008007149A3 New medical use of triazine derivatives |
| 03/13/2008 | WO2008005624A3 Method of treatment of hereditary hemochromatosis |